United Therapeutics (UTHR) Misses Q3 EPS by 16c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $512.70 +0.45%
EPS Growth %: -10.1%
Financial Fact:
Operating income: 238.6M
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: -10.1%
Financial Fact:
Operating income: 238.6M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $7.16, $0.16 worse than the analyst estimate of $7.32. Revenue for the quarter came in at $799.5 million versus the consensus estimate of $812.87 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Starts Amplifon SpA (AMP:IM) (AMFPF) at Overweight
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- Morgan Stanley Upgrades Coloplast A/S (COLOB:DC) (CLPBY) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
